.Merck trumps earnings assumptions, rears sales expectation on tough requirement for top medicines like Keytruda CNBCMerck & Co. (MRK US) Beats Earnings Forecasts as Keytruda Purchases Rise BloombergMerck Inventory: Pharma Titan Posts Solid End Results, Yet Expectation Falls Short Capitalist's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps profit and also purchases desires in the middle of Keytruda strong point, yet gives mixed full-year outlook MarketWatch.